Elemind: Wearable AI offers ‘electric medicine’ via brain stimulation
ReadWriteStart
FEBRUARY 8, 2024
The first round of seed investment has pulled in $12 million for the program, following multiple studies proving its efficacy, it was announced on Tuesday (Feb.6). Elemind offers a non-chemical, direct, and on-demand solution that learns and dynamically adjusts to each person,” said Meredith Perry, CEO and co-founder of Elemind.
Let's personalize your content